Hikaru Ito Selected Research

Hikaru Ito Research Topics

3	Inflammation (Inflammations) 01/2020 - 01/2015
3	Intellectual Disability (Idiocy) 02/2016 - 11/2009
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2015 - 03/2012
2	Huntington Disease (Huntington's Disease) 11/2008 - 07/2008
1	Neuroinflammatory Diseases 01/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Anorexia 12/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018
1	Nervous System Diseases (Neurological Disorders) 02/2016
1	Fibrosis (Cirrhosis) 08/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Renal Insufficiency (Renal Failure) 01/2015
1	Disease Progression 01/2015
1	Microcephaly 01/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2011
1	Postmortem Changes (Adipocere) 01/2011
1	Carcinogenesis 01/2010

3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2011
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2020 - 07/2008
2	Histones (Histone)IBA 01/2018 - 02/2016
2	PhosphoproteinsIBA 01/2015 - 01/2011
2	Ataxin-1IBA 01/2015 - 03/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 11/2008
2	HMGB1 Protein (HMG1)IBA 01/2015 - 11/2008
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	ONO-2952IBA 01/2020
1	Phosphotransferases (Kinase)IBA 12/2019
1	Type C PhospholipasesIBA 12/2019
1	CytokinesIBA 12/2019
1	NF-kappa B (NF-kB)IBA 12/2019
1	LipopolysaccharidesIBA 12/2019
1	Lysine (L-Lysine)FDA Link 02/2016
1	ChromatinIBA 02/2016
1	Urea (Carbamide)FDA LinkGeneric 08/2015
1	PotassiumIBA 08/2015
1	SodiumIBA 08/2015
1	PhosphopeptidesIBA 01/2015
1	CreatinineIBA 01/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2015
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2015
1	Receptor for Advanced Glycation End ProductsIBA 01/2015
1	Mitochondrial DNA (mtDNA)IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 03/2012
1	Ataxin-7IBA 03/2012
1	ProteomeIBA 01/2011
1	gamma-Aminobutyric Acid (GABA)IBA 01/2010
1	polyglutamineIBA 11/2009
1	Carrier Proteins (Binding Protein)IBA 11/2009